Tareq Abadl: Massive Transfusion – The Hidden Citrate Risk
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
“Did you know that during massive transfusion, one hidden danger is not the blood type – but the anticoagulant inside the blood bag?
Blood components are stored with citrate to prevent clotting.
During massive transfusion, large amounts of citrate can bind calcium and magnesium in the patient’s bloodstream, leading to citrate toxicity and hypocalcemia.
Why does this matter?
Because calcium is critical for:
- Cardiac contractility
- Coagulation pathways
- Neuromuscular function
- Cellular stability.
When citrate accumulates faster than the body can metabolize it, patients may develop:
- Hypotension
- Reduced ventricular function
- Arrhythmias
- Coagulopathy
- Tetany or increased neuromuscular excitability.
Under normal conditions, citrate is rapidly metabolized through the Krebs cycle, mainly by the liver, kidneys, and skeletal muscle. But in trauma, shock, hypothermia, liver dysfunction, or poor tissue perfusion, citrate clearance decreases significantly – making toxicity more likely during rapid transfusion.
An important point in transfusion medicine:
- Hypocalcemia in massive transfusion is often dilutional and citrate-related at the same time.
That is why modern Massive Transfusion Protocols (MTPs) emphasize:
- Monitoring ionized calcium
- Early calcium replacement
- Close assessment of coagulation and electrolytes
Prevention of the ‘lethal triad’:
- Hypothermia
- Coagulopathy
- Acidosis.
Another interesting blood bank fact:
- Plasma and platelets usually contain more citrate than packed RBCs, so the risk may increase when large amounts of these components are transfused rapidly.
This is a powerful reminder that transfusion safety is not only about ABO and Rh compatibility.
Blood bank science also involves understanding metabolic, electrolyte, and coagulation complications during emergency transfusion support.”
Other posts featuring Tareq Abadl on Hemostasis Today.
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time